{"id":"paper-biocell-2026-085785","type":"book","url":"https://diginpl.com/books/paper-biocell-2026-085785","language":"en","name":"SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways","name_en":"SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways","name_ne":null,"description":"BIOCELL · Wentao Ou, Zijian He, Wencong Zhou et al. · 2026","headline":"BIOCELL · Wentao Ou, Zijian He, Wencong Zhou et al. · 2026","also_known_as":[],"summary":"","summary_more":[],"facts":[{"key":"authors","label":"Author","values":[{"text":"Wentao Ou"},{"text":"Zijian He"},{"text":"Wencong Zhou"},{"text":"Yao Liu"},{"text":"Yaoxing Huang"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/biocell.2026.085785"}},{"key":"published","label":"Published","values":[{"text":"2026","date":"2026"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/biocell.2026.085785"}},{"key":"publisher","label":"Publisher","values":[{"text":"Tech Science Press"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/biocell.2026.085785"}},{"key":"journal","label":"Journal","values":[{"text":"BIOCELL"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/biocell.2026.085785"}},{"key":"doi","label":"DOI","values":[{"text":"10.32604/biocell.2026.085785","url":"https://doi.org/10.32604/biocell.2026.085785"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/biocell.2026.085785"}}],"office":null,"sections":[],"cited":[],"cited_from":null,"videos":[],"last_reviewed":null,"organizations":[],"same_as":["https://doi.org/10.32604/biocell.2026.085785"],"faq":[{"q":"Who wrote SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways?","a":"SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways was written by Wentao Ou, Zijian He, Wencong Zhou, Yao Liu."},{"q":"When was SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways first published?","a":"SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways was first published in 2026."}],"related":[],"places_in":[],"nearby":[],"image":null,"sources":[{"label":"Publisher record (DOI, via Crossref)","url":"https://doi.org/10.32604/biocell.2026.085785","license":null}],"license":null,"attribution":"Open-access publication. Read it free at the publisher: https://doi.org/10.32604/biocell.2026.085785.","cite":"\"SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways\". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-biocell-2026-085785. Retrieved 14 November 2026.","date_modified":"2026-10-02T00:04:53Z","facts_checked":"2026-11-02","alternates":{"html":"https://diginpl.com/books/paper-biocell-2026-085785","en":"https://diginpl.com/books/paper-biocell-2026-085785","ne":null}}